CRIS Current Research Information System

LICCHETTA, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.061
AS - Asia 8.119
EU - Europa 5.483
Continente sconosciuto - Info sul continente non disponibili 563
SA - Sud America 489
AF - Africa 401
OC - Oceania 19
Totale 24.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.810
SG - Singapore 2.125
VN - Vietnam 2.062
CN - Cina 1.910
IT - Italia 1.555
GB - Regno Unito 965
DE - Germania 708
HK - Hong Kong 581
SE - Svezia 577
BR - Brasile 363
BD - Bangladesh 353
FR - Francia 324
IN - India 308
NL - Olanda 286
RU - Federazione Russa 242
KR - Corea 226
IE - Irlanda 183
CA - Canada 157
UA - Ucraina 139
JP - Giappone 136
FI - Finlandia 126
CI - Costa d'Avorio 115
ZA - Sudafrica 108
JO - Giordania 70
EE - Estonia 55
AR - Argentina 51
AT - Austria 50
BG - Bulgaria 50
TG - Togo 48
PH - Filippine 45
ID - Indonesia 44
MX - Messico 43
CH - Svizzera 42
SC - Seychelles 42
IQ - Iraq 39
ES - Italia 38
TR - Turchia 34
TH - Thailandia 32
PL - Polonia 30
PK - Pakistan 28
BE - Belgio 27
NG - Nigeria 26
UZ - Uzbekistan 22
EC - Ecuador 18
GR - Grecia 17
TW - Taiwan 17
SA - Arabia Saudita 16
CO - Colombia 15
AU - Australia 14
MY - Malesia 14
CL - Cile 13
JM - Giamaica 13
PY - Paraguay 11
EG - Egitto 10
PT - Portogallo 10
IL - Israele 9
MA - Marocco 9
RO - Romania 9
TN - Tunisia 8
IR - Iran 7
KE - Kenya 7
LB - Libano 7
LT - Lituania 7
PE - Perù 7
VE - Venezuela 7
CR - Costa Rica 6
HU - Ungheria 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
HR - Croazia 5
KZ - Kazakistan 5
NI - Nicaragua 5
NP - Nepal 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
GT - Guatemala 4
HN - Honduras 4
LV - Lettonia 4
NO - Norvegia 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
CG - Congo 3
CM - Camerun 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AL - Albania 2
GH - Ghana 2
KG - Kirghizistan 2
KH - Cambogia 2
MD - Moldavia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
Totale 23.545
Salva come PNG Salva come JPEG
Città #
Singapore 1.506
Ashburn 1.023
Southend 708
Fairfield 700
Hong Kong 557
Hefei 500
Chandler 498
Ho Chi Minh City 494
Hanoi 442
San Jose 409
Woodbridge 338
Seattle 331
Houston 321
Santa Clara 307
Wilmington 293
Council Bluffs 263
Cambridge 253
Beijing 249
Ann Arbor 237
Bologna 213
Seoul 211
Princeton 207
Dublin 182
Boardman 180
New York 164
Dallas 159
Los Angeles 153
Lauterbourg 144
Tokyo 122
Turin 119
Milan 117
Abidjan 115
Dong Ket 114
Rome 83
Helsinki 80
Redmond 79
Westminster 78
Munich 76
Jacksonville 75
Berlin 70
Buffalo 70
Nanjing 70
Amman 69
Florence 69
Montréal 67
Redondo Beach 65
Haiphong 63
Da Nang 61
Frankfurt am Main 57
Padova 57
Chicago 49
Sofia 49
São Paulo 49
Lomé 48
Saint Petersburg 48
Mcallen 46
Amsterdam 44
Jinan 43
Modena 43
Bengaluru 42
Nuremberg 42
Shanghai 41
Naples 40
London 39
San Diego 37
Lappeenranta 33
Orem 33
Shenyang 33
Bern 32
Phoenix 32
Vienna 32
Hải Dương 30
Biên Hòa 29
Guangzhou 28
Johannesburg 28
Jakarta 27
Changsha 26
Nanchang 26
Tianjin 25
Castel Maggiore 24
Falls Church 24
Thái Nguyên 24
Toronto 24
Atlanta 23
Brussels 23
Abeokuta 22
Can Tho 22
Zhengzhou 22
Dearborn 21
Des Moines 21
Warsaw 21
Brooklyn 20
Düsseldorf 20
San Francisco 20
Mülheim 19
Lahore 18
Medford 18
Redwood City 18
Rimini 18
Falkenstein 17
Totale 14.331
Salva come PNG Salva come JPEG
Nome #
Clinical features and pathophysiology of disorders of arousal in adults: A window into the sleeping brain 481
Prognostic value of pathogenic variants in Lafora Disease: systematic review and meta-analysis of patient-level data 404
The Arousal Disorders Questionnaire: a new and effective screening tool for confusional arousals, Sleepwalking and Sleep Terrors in epilepsy and sleep disorders units 335
Clinical characterization of non-ketotic hyperglycemia-related seizures: A systematic review and individual participant data meta-analysis 277
LGI1 microdeletions are not a frequent cause of partial epilepsy with auditory features (PEAF). 257
Adult patients with intellectual disability and epilepsy: clinical and genetic study of 114 cases 253
Contribution of ultrarare variants in mTOR pathway genes to sporadic focal epilepsies 249
A seizure response dog: video recording of reacting behaviour during repetitive prolonged seizures. 238
Auditory aura in nocturnal frontal lobe epilepsy: a red flag to suspect an extra-frontal epileptogenic zone 236
Accurate Detection of Hot-Spot MTOR Somatic Mutations in Archival Surgical Specimens of Focal Cortical Dysplasia by Molecular Inversion Probes 233
Autosomal dominant partial epilepsy with auditory features: A new locus on chromosome 19q13.11-q13.31. 231
Profile of neuropsychological impairment in Sleep-related Hypermotor Epilepsy 231
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health 229
Ictal Bradycardia and Asystole in Sleep-Related Hypermotor Epilepsy: A Study of 200 Patients 223
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy 221
Epilepsy With Auditory Features: From Etiology to Treatment 221
Cerebral areas involved in music perception: studying musicogenic epilepsy. 220
GATOR1 complex: the common genetic actor in focal epilepsies 215
Behçet disease presenting with movement disorders and antibasal ganglia antibodies 212
Effect of valproic acid on perampanel pharmacokinetics in patients with epilepsy. 212
Defective lipid signalling caused by mutations in PIK3C2B underlies focal epilepsy 210
PRIMA1 mutation: a new cause of nocturnal frontal lobe epilepsy 210
Epilepsy with auditory features: Contribution of known genes in 112 patients 209
Epilepsy with auditory features: Long-term outcome and predictors of terminal remission 207
Polysomnographic features differentiating disorder of arousals from sleep-related hypermotor epilepsy 207
Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals 206
Fattori prognostici in 170 pazienti con epilessia temporale mesiale 201
Incidence of sudden unexpected death in nocturnal frontal lobe epilepsy: a cohort study. 200
FDG-PET assessment and metabolic patterns in Lafora disease 199
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 199
Response to the letter "New avenues to prevent sudden unexpected death in nocturnal frontal lobe epilepsy: follow the route established by omega-3 polyunsaturated fatty acids". 196
A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy 196
Definition and diagnostic criteria of sleep-related hypermotor epilepsy 196
Epilepsy with auditory features: A heterogeneous clinico-molecular disease 194
Quantitative dried blood spot microsampling for therapeutic drug monitoring of -antiseizure medications by design of experiment and UHPLC-MS/MS 193
Ictal vasodepressive syncope in temporal lobe epilepsy 192
Seizures with paroxysmal arousals in sleep-related hypermotor epilepsy (SHE): Dissecting epilepsy from NREM parasomnias 192
Phenotype variability of GLUT1 deficiency syndrome: Description of a case series with novel SLC2A1 gene mutations 190
Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late 190
Epilepsy in MT-ATP6 - related mils/NARP: correlation of elettroclinical features with heteroplasmy 190
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational study 189
VAL-1221 for the treatment of patients with Lafora disease: Study protocol for a single-arm, open-label clinical trial 186
Juvenile absence epilepsy relapsing as recurrent absence status, mimicking transient global amnesia, in an elderly patient 185
Treatment with metformin in twelve patients with Lafora disease 184
FDG-PET findings and alcohol-responsive myoclonus in a patient with Unverricht-Lundborg disease 183
Specific motor patterns of arousal disorders in adults: A video-polysomnographic analysis of 184 episodes 181
Epilepsy in ring chromosome 20 syndrome 179
Prevalence of Nocturnal Frontal Lobe Epilepsy in the Adult Population of Bologna and Modena, Emilia-Romagna Region, Italy. 176
A case of clinical worsening after stereo-electroencephalographic-guided radiofrequency thermocoagulation in a patient with polymicrogyria 175
Sleep-related hypermotor epilepsy (SHE): Contribution of known genes in 103 patients 175
Risk of hospitalization and death for COVID-19 in persons with epilepsy over a 20-month period: The EpiLink Bologna cohort, Italy 174
Ictal characteristics of psychogenic nonepileptic seizures: what we have learned from video/EEG recordings - a literature review. 171
Cortical myoclonic tremor induced by fixation-off sensitivity: An unusual cause of insomnia 171
Increased frequency of arousal parasomnias in families with nocturnal frontal lobe epilepsy: a common mechanism? 171
Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real-world study 170
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy. 170
Neuropsychological impairment in patients with early onset nocturnal frontal lobe epilepsy. 167
Tailored surgery for drug-resistant epilepsy due to temporal pole encephalocele and microdysgenesis. 167
Proton MR spectroscopy in patients with sleep-related hypermotor epilepsy (SHE): Evidence of altered cingulate cortex metabolism 167
Epilepsy and inborn errors of metabolism in adults: The diagnostic odyssey of a young woman with medium-chain acyl-coenzyme A dehydrogenase deficiency 166
Complete Agenesis of Corpus Callosum in KCNQ2-Related Neonatal Epileptic Encephalopathy 166
Epilepsy in coeliac disease: not just a matter of calcifications. 166
Nocturnal motor behaviors with unexpected EEG and brain MRI findings 165
Biallelic pathogenic variants of PARS2 cause developmental and epileptic encephalopathy with spike-and-wave activation in sleep 164
Health-related quality of life in epilepsy: findings obtained with a new Italian instrument. 162
Therapy in Sleep-Related Hypermotor Epilepsy (SHE) 162
Extended Glasgow Outcome Scale to Evaluate the Functional Impairment of Patients With Subcortical Band Heterotopia: A Multicentric Cross-sectional Study 158
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 157
Health-related quality of life in patients with Nocturnal Frontal Lobe Epilepsy. 157
Secondary sclerosing cholangitis in critically ill patients with febrile infection-related epilepsy syndrome (FIRES): a case series 156
Intronic ATTTC repeat expansions in STARD7 in familial adult myoclonic epilepsy linked to chromosome 2 156
The Impact of the COVID-19 Pandemic on People With Epilepsy. An Italian Survey and a Global Perspective 155
Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. 153
Epilepsy with eyelid myoclonias and Sotos syndrome features in a patient with compound heterozygous missense variants in APC2 gene 153
If seizures left speechless: CA-P-S C-A-R-E, a proposal of a new ictal language evaluation protocol 152
Neuropsychological assessment in patients with early onset nocturnal frontal lobe epilepsy. 151
Progressive myoclonic epilepsies: definitive and still undetermined causes 150
Limbic encephalitis with anti-GAD antibodies and Thomsen myotonia: A casual or causal association? 150
A Novel Mutation af Cln3 Associated with Delayed-Classic Juvenile Ceroid Lipofucinois and Autophagic Vacuolar Myopathy 149
Identity by descent fine mapping of familial adult myoclonus epilepsy (FAME) to 2p11.2–2q11.2 149
Diagnosis and misdiagnosis of adult neuronal ceroid lipofuscinosis (Kufs disease) 149
Progressive Myoclonus Epilepsies Diagnostic Yield with Next-Generation Sequencing in Previously Unsolved Cases 149
Polygenic burden in focal and generalized epilepsies 147
MECP2 duplication syndrome: The electroclinical features of a case with long-term evolution 146
Prognostic factors in patients with Mesial Temporal Lobe Epilepsy (MTLE): A preliminary study. 145
Pseudohyperkalemia due to cryohydrocytosis in GLUT1 deficiency syndrome. A case report and literature review 144
Super refractory status epilepticus in Lafora disease interrupted by vagus nerve stimulation: A case report 144
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. 144
Tobacco habits in nocturnal frontal lobe epilepsy 143
The landscape of epilepsy-related GATOR1 variants 140
A stereo EEG study in a patient with sleep-related hypermotor epilepsy due to DEPDC5 mutation 139
Epilepsy with Bilateral Hippocampal Hyperintensity and Celiac Disease: Comorbidity or a real association? 137
SCN1A mutations in focal epilepsy with auditory features: widening the spectrum of GEFS plus 137
Mutations in DEPDC5 cause familial focal epilepsy with variable foci. 135
DEPDC5 mutations in epilepsy with auditory features 135
Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K(+) channel properties 135
A survey of the European Reference Network EpiCARE on clinical practice for selected rare epilepsies 134
Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations 132
Identification of genes responsible for Nocturnal Frontal Lobe Epilepsy (NFLE): role of DEPDC5 mutations 130
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 130
Totale 18.588
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.570
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.955 0 62 111 206 191 104 57 147 109 265 402 301
2022/20232.300 227 290 105 254 175 165 78 117 409 104 281 95
2023/2024821 56 118 54 100 59 147 31 71 31 68 36 50
2024/20253.197 96 458 209 244 394 134 155 103 49 342 212 801
2025/20269.944 1.073 1.022 819 820 873 446 953 343 1.634 737 575 649
2026/2027843 422 421 0 0 0 0 0 0 0 0 0 0
Totale 24.135